EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Retinoic acid and ascorbate synergize to suppress myeloid leukemia via TET2 activation

Tiffany E Leesang, John P Brabson, Yoon Sing Yap, Daniela A Barbieri, Abigail S Klimas, Joey Pinzone, Emily L Ahearn, Minh Q Lam, Peter D Lyon, Anna Swirski, Nicholas B Wolfe, Yuichiro Nakata und 9 weitere

Cell Reports · 2025

DOI: 10.1016/j.celrep.2025.116379 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2025. Verfasst von Tiffany E Leesang und 20 weiteren Autor:innen. Beteiligte Einrichtung: University of Miami, Miller School of Medicine, Department of Biochemistry and Molecular Biology, Miami, FL 33136, USA; Sylvester Comprehensive Cance…. Hauptthemen laut MEDLINE: Ascorbic Acid, Tretinoin, DNA-Binding Proteins, Proto-Oncogene Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, National Institute of General Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ascorbic AcidTretinoinDNA-Binding ProteinsProto-Oncogene ProteinsLeukemia, Myeloid, AcuteLeukemia, MyeloidAnimalsDioxygenasesHumansMiceCell Line, TumorCell DifferentiationDrug SynergismRetinoic Acid Receptor alphaDNA MethylationNeoplastic Stem Cells

Stichwörter der Autor:innen

5hmCCP: CancerCP: GenomicsTET2ascorbatedifferentiation therapymyeloid leukemiaretinoic acid

Substanzen

Ascorbic AcidDioxygenasesTretinoinDNA-Binding ProteinsProto-Oncogene ProteinsTET2 protein, humanTet2 protein, mouseRetinoic Acid Receptor alpha

Autor:innen und Institutionen

  • University of Miami, Miller School of Medicine, Department of Biochemistry and Molecular Biology, Miami, FL 33136, USA; Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, FL 33…
  • Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, FL 33136, USA.
  • Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, FL 33136, USA; Department of Human Genetics, University of Miami, Miller School of Medicine, Miami, FL 33136, USA.
  • Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, FL 33136, USA; Department of Medicine, Division of Hematology, University of Miami, Miller School of Medicine, Miami, FL 3313…

Förderung

  • NCI NIH HHS
  • NIGMS NIH HHS
  • National Institute of General Medical Sciences
  • National Institutes of Health National Cancer Institute

Zitieren

APA

Leesang, T. E., Brabson, J. P., Yap, Y. S., Barbieri, D. A., Klimas, A. S., Pinzone, J., Ahearn, E. L., Lam, M. Q., Lyon, P. D., Swirski, A., Wolfe, N. B., Nakata, Y., Dos Santos, H. G., Shiekhattar, R., Morey, L., Vlantis, P. I., Figueroa, M. E., Chandhok, N., Beckedorff, F., …, & Cimmino, L. (2025). Retinoic acid and ascorbate synergize to suppress myeloid leukemia via TET2 activation. Cell Reports. https://doi.org/10.1016/j.celrep.2025.116379

Vancouver

Leesang TE, Brabson JP, Yap YS, Barbieri DA, Klimas AS, Pinzone J, et al. Retinoic acid and ascorbate synergize to suppress myeloid leukemia via TET2 activation. Cell Reports. 2025. doi:10.1016/j.celrep.2025.116379

BibTeX
@article{Leesang2025,
  author = {Leesang, Tiffany E and Brabson, John P and Yap, Yoon Sing and Barbieri, Daniela A and Klimas, Abigail S and Pinzone, Joey and Ahearn, Emily L and Lam, Minh Q and Lyon, Peter D and Swirski, Anna and Wolfe, Nicholas B and Nakata, Yuichiro and Dos Santos, Helena Gomes and Shiekhattar, Ramin and Morey, Lluis and Vlantis, Panayiotis I and Figueroa, Maria E and Chandhok, Namrata and Beckedorff, Felipe and Telonis, Aristeidis G and Cimmino, Luisa},
  title = {Retinoic acid and ascorbate synergize to suppress myeloid leukemia via TET2 activation},
  journal = {Cell Reports},
  year = {2025},
  doi = {10.1016/j.celrep.2025.116379}
}
Kostenlos starten →